RT @infosalut: #PublicaSalutIB Prevalencia de las potenciales interacciones entre medicamentos para el tratamiento con fármacos antineoplás…
RT @bibliosalut: #PublicaSalutIB Prevalença de les potencials interaccions entre medicaments per al tractament amb fàrmacs antineoplàsics p…
#PublicaSalutIB Prevalença de les potencials interaccions entre medicaments per al tractament amb fàrmacs antineoplàsics parenterals https://t.co/sHbZABYSRo @elfarodehuse https://t.co/J6zlsISCSf https://t.co/zBkjvH7iWa
RT @infosalut: #PublicaSalutIB Prevalencia de las potenciales interacciones entre medicamentos para el tratamiento con fármacos antineoplás…
#PublicaSalutIB Prevalencia de las potenciales interacciones entre medicamentos para el tratamiento con fármacos antineoplásicos parenterales https://t.co/5jqIyieTma @elfarodehuse https://t.co/gmWIsWSzSw @SonEspases https://t.co/sPeQwfAfkk
RT @elfarodehuse: [IJCP] "26.7% of clinically relevant potential drug–drug interactions" Prevalence of potential drug–drug interactions in…
RT @elfarodehuse: [IJCP] "26.7% of clinically relevant potential drug–drug interactions" Prevalence of potential drug–drug interactions in…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @elfarodehuse: [IJCP] "26.7% of clinically relevant potential drug–drug interactions" Prevalence of potential drug–drug interactions in…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @elfarodehuse: [IJCP] "26.7% of clinically relevant potential drug–drug interactions" Prevalence of potential drug–drug interactions in…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
RT @Olguitxi: Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4…
Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs 1 de cada 4 pacientes presenta una potencial interacción clínicamente relevante. @elfarodehuse @SonEspases @mariatwit3 @fdo_pazo https://t.
RT @elfarodehuse: [IJCP] "26.7% of clinically relevant potential drug–drug interactions" Prevalence of potential drug–drug interactions in…
RT @elfarodehuse: [IJCP] "26.7% of clinically relevant potential drug–drug interactions" Prevalence of potential drug–drug interactions in…
[IJCP] "26.7% of clinically relevant potential drug–drug interactions" Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs https://t.co/i3vHKuQWkl @mariatwit3 @infosalut